Filing Details

Accession Number:
0000711377-18-000022
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-07-24 12:51:08
Reporting Period:
2018-07-20
Accepted Time:
2018-07-24 12:51:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1188987 A Terri Morrical Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-07-20 15,468 $35.34 53,043 No 4 M Direct
Common Stock Disposition 2018-07-20 15,468 $82.14 37,575 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2018-07-20 15,468 $0.00 15,468 $35.34
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
125,602 2020-11-08 No 4 M Direct
Footnotes
  1. Options were granted 10/8/2015, have five year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the grant